BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-2.44 Cr | ₹2.71 Cr | ₹0.37 Cr | ₹0.09 Cr | ₹0.17 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-2.44 Cr |
| Mar2024 | ₹2.71 Cr |
| Mar2023 | ₹0.37 Cr |
| Mar2022 | ₹0.09 Cr |
| Mar2021 | ₹0.17 Cr |
How is Net Cash Inflow / Outflow of BAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.44 Cr | Negative | |
| Mar2024 | ₹2.71 Cr | 624.33 | |
| Mar2023 | ₹0.37 Cr | 320.22 | |
| Mar2022 | ₹0.09 Cr | -47.02 | |
| Mar2021 | ₹0.17 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹115.6 Cr | -1.6% | -0.9% | -43% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -1.6% |
-0.9% |
-43% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses